APA

Schühlen H., Abts M. & Kastrati D. (20071113). [Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study]. : Herz.

Chicago

Schühlen Helmut, Abts Markus and Kastrati Dorejd. 20071113. [Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study]. : Herz.

Harvard

Schühlen H., Abts M. and Kastrati D. (20071113). [Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study]. : Herz.

MLA

Schühlen Helmut, Abts Markus and Kastrati Dorejd. [Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study]. : Herz. 20071113.